Levetiracetam 1 A Pharma

Levetiracetam, the active ingredient in Levetiracetam 1 A Pharma, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control seizure activity across several seizure disorders. - Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes that involve the whole brain. - Myoclonic seizures: diminishes sudden, brief muscle jerks characteristic of this seizure type.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness not relieved by rest. - Headache: mild to moderate cranial pain. - Irritability: increased emotional sensitivity. - Nasopharyngitis: upper respiratory tract infection symptoms. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Mood changes: depression or suicidal thoughts. - Aggression or hostility: marked behavioral alterations. - Blood disorders: signs of anemia or low platelet count. - Hepatic dysfunction: jaundice or abnormal liver enzymes. - Stevens‑Johnson syndrome: severe skin blistering.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific concerns. - Renal impairment: adjust dose based on creatinine clearance. - Hepatic disease: use with caution, monitor liver function. - Psychiatric history: observe for mood or behavioral changes. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy and lactation: discuss unknown safety profile with the patient. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Fluoroquinolone antibiotics: increased risk of CNS side effects. - Opioids: potential for enhanced sedation. - Alcohol: may exacerbate dizziness and drowsiness. - Other antiepileptics: monitor overall seizure control and side‑effect burden.